Other reports have also confirmed the synergistic effect of BET inhibitors on Cisplatin, Carboplatin, and Paclitaxel against ovarian cancer [42], NSCLC [43], prostate cancer [44], and breast cancer [45]. This evidence concerns the gene DNER and non-small cell lung carcinoma.